Issue 18/2012
Content (11 Articles)
Can a New Ultra-Long-Acting Insulin Analogue Improve Patient Care? Investigating the Potential Role of Insulin Degludec
- Current Opinion
Jennifer D. Robinson, Joshua J. Neumiller, R. Keith Campbell
US Food and Drug Administration’s Risk Evaluation and Mitigation Strategy for Extended-Release and Long-Acting Opioids
- Current Opinion
Sebastiano Mercadante, David Craig, Antonello Giarratano
Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel Disease
- Review Article
Guru Trikudanathan, Preethi G. K. Venkatesh, Udayakumar Navaneethan
Primary Prevention of Major Cardiovascular and Cerebrovascular Events with Statins in Diabetic Patients
- Systematic Review
Folgerdiena M. de Vries, Petra Denig, Koen B. Pouwels, Maarten J. Postma, Eelko Hak
Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™)
- Adis Drug Evaluation
Jamie D. Croxtall, Sohita Dhillon